-
Jan 15, 2025 | 
the-rheumatologist.org | Jason Liebowitz
BALTIMORE—Many rheumatologists are aware of the 1975 Bohan and Peter criteria for the diagnosis of dermatomyositis and polymyositis, but fewer have been willing to reconsider these criteria in the era of recognized myositis-associated autoantibodies and their correlated phenotypes.1,2 At the 20th Annual Advances in the Diagnosis and Treatment of the Rheumatic Diseases Symposium at Johns Hopkins School of Medicine, Lisa Christopher-Stine, MD, MPH, professor of medicine, director of the...
-
Jan 15, 2025 | 
the-rheumatologist.org | Jason Liebowitz
BALTIMORE—Although first described by the English physician Sir Jonathan Hutchinson in the 1870s, sarcoidosis remains a prevalent—and insidious—disease in the modern world. At the 20th Annual Advances in the Diagnosis and Treatment of the Rheumatic Diseases Symposium at Johns Hopkins School of Medicine, Baltimore, Michelle Sharp, MD, MHS, assistant professor of medicine and co-director of the Johns Hopkins Sarcoidosis Program, provided a thorough lecture titled, Updates in Sarcoidosis.
-
Jan 2, 2025 | 
theatlantic.com | Jason Liebowitz
In the summer of 2018, 59-year-old David Gould went for his annual checkup, expecting to hear the usual: Everything looks fine. Instead, he was told that he was newly—and oddly—anemic. Two months later, Gould began to experience a strange cascade of symptoms. His ankles swelled to the width of his calves. The right side of his face became so bloated that he could not open his eye. He developed a full-body rash, joint pain, fever, and drenching night sweats.
-
Jan 1, 2025 | 
the-rheumatologist.org | Jason Liebowitz
BALTIMORE—At the 20th Annual Advances in the Diagnosis and Treatment of the Rheumatic Diseases symposium at Johns Hopkins School of Medicine, Jun Kang, MD, assistant professor of dermatology, Johns Hopkins School of Medicine, Baltimore, regaled the audience with his talk, Dermatology and Rheumatic Disease. He discussed a stepwise approach to evaluating skin lesions and helping patients receive proper diagnoses and treatments.
-
Jan 1, 2025 | 
the-rheumatologist.org | Jason Liebowitz
BALTIMORE—The autonomic nervous system is a marvel of coordinated physiology, but when things go awry, the resulting symptoms patients experience can be severe.
-
Dec 20, 2024 | 
the-rheumatologist.org | Jason Liebowitz
WASHINGTON, D.C.—It is no small task to summarize an entire year’s worth of research accomplishments in any field of medicine, let alone one as complex as rheumatology. At ACR Convergence 2024, the Pediatric Year in Review not only provided a thoughtful summary, but also grouped advances along several different themes. Jessica Turnier, MD, MS, assistant professor of pediatric rheumatology, University of Michigan, Saline, began her talk by discussing new tools being used to study immune health.
-
Dec 4, 2024 | 
the-rheumatologist.org | Jason Liebowitz
WASHINGTON, D.C.—Randomized clinical trials (RCTs) are the gold standard for testing medical interventions. However, researchers are using multiple new and creative ways to design these trials to account for real-world scenarios and produce information relevant to practicing clinicians. At ACR Convergence 2024, the session Innovative Clinical Trials: Precision, Design and Optimization provided tremendous insights into these important topics. The first speaker, Kelli D.
-
Dec 4, 2024 | 
the-rheumatologist.org | Jason Liebowitz
WASHINGTON, D.C.—Although 365 days is a long time to account for when it comes to advances in a field such as rheumatology, the two speakers at the ACR Convergence 2024 Year in Review lecture did a wonderful job summarizing key highlights. The first speaker was Michael Pillinger, MD, professor of medicine and of biochemistry and molecular pharmacology at New York University Grossman School of Medicine, who provided the clinical year in review talk.
-
Nov 23, 2024 | 
the-rheumatologist.org | Jason Liebowitz
WASHINGTON, D.C.—Many physicians have dreams of becoming physician-writers—to see their work published in The Journal of the American Medical Association’s A Piece of My Mind column or in The New York Times—but few feel confident they have the skills and knowledge to pursue these goals. At the ACR Convergence 2024 session The Fundamentals of Narrative Medicine, two outstanding speakers regaled the audience with stories and practical tips on this very subject.
-
Nov 20, 2024 | 
the-rheumatologist.org | Jason Liebowitz
WASHINGTON, D.C.—People seek—or don’t seek—an evaluation with a rheumatologist for many reasons, and seeing what we can glean from such situations helps inform us about the phases of, and risk factors for, autoimmune disease. At ACR Convergence 2024, the session Risk Stratification for Future Rheumatoid Arthritis provided brilliant insights into this topic and enlightened the audience with international data.
